GLP-1 is a hormone produced naturally in the body that plays a crucial role in regulating blood sugar levels, appetite, and other metabolic processes
Sanjay Gupta reports
Unfortunately, given the costs that go into clinical trials and the fact that potentially hundreds of thousands of people are already taking these peptides (so theres already a market driving profit), theres a strong possibility that a new robust clinical trial may never be done on BPC-157
However, more recent studies have demonstrated that the hepatic biosynthesis of AGT is the major source of renal ANG II concentrations and its renal expression depends on the integrity of the glomerular sieving function ( In fact, when the glomerular capillary wall, acting as a molecular barrier, is impaired, AGT protein is leaked into the tubular lumen and then reabsorbed at S1, S2 and S3 segments of proximal convoluted tubules ( The AGT reabsorption is a megalin-dependent process
In STEP 1, the phase 3 trial that led to semaglutide's approval for obesity, participants lost about 15% of their body weight over a year
Treatment decisions are based on individual clinical assessment
.webp)
